In Europe, the annual incidence rates of generalised convulsive status epilepticus range from 3.6 to 6.6 per 100,000 population. The annual incidence rates for non-convulsive status epilepticus range from 2.6 to 7.8 per 100,000 population.
Status epilepticus can equally occur in patients with an established diagnosis of epilepsy or as the first unprovoked seizure in patients with no known history of epilepsy. In patients with epilepsy, status epilepticus is more likely to occur in those with refractory seizures of focal onset, whether or not there is known structural aetiology.
Stroke is the leading cause of SE among acute symptomatic cases.
Examples include disturbances in water, glucose, and electrolyte metabolism.
Chronic or refractory epilepsy is a risk factor for developing status epilepticus. This was observed in several clinical trials involving patients with pharmacoresistant epilepsy.
Other than stroke (ischaemic, haemorrhagic), examples include hypoxic-ischaemic brain injury, head trauma, stroke (ischaemic, haemorrhagic), subarachnoid haemorrhage, tumours, brain abscess, and other brain infections (meningitis, encephalitis).
This includes substance use of certain restricted or recreational drugs such as cocaine and amphetamines. Also, certain prescription drugs (e.g., theophylline, bupropion, tramadol, or isoniazid) may in rare cases precipitate status epilepticus.
Use of this content is subject to our disclaimer